Latest filing published 18 Mar 2026 for Cumberland Pharmaceuticals INC, €16k. Read the official filing
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of A. J. Kazimi in Cumberland Pharmaceuticals Inc. Over a trading history stretching from 17 March 2021 to 16 March 2026, the count stands at 36 filings.
No open-market sale appears; the market trades are 17 purchases worth €807. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 6 share grants.
The median purchase comes to €38. Clusters matter here: 17 out of 17 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 18 March 2026, the filings show a share grant worth €16k in Cumberland Pharmaceuticals Inc. The last purchase on record was published on 12 September 2025, which is 401 days ago. Filings reach the SEC (Form 4) feed a median of 34 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 36 declarations